Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury
After multiple doses, mean IGF-1 levels remained above baseline for up to 28 days, with no serious adverse reactions reported establishing the GHRH-analogue backbone as capable of sustained, clinically meaningful GH and IGF-1 axis elevation
Both have been studied for their potential to influence growth hormone release in research models during clinical trials
683,685 Nutritional support and medications are used to manage complications, with corticosteroids currently the only approved treatment for severe AH
Sulfite Alters the Mitochondrial Network in Molybdenum Cofactor Deficiency
Other mechanisms In addition to the aforementioned well-established therapies, numerous other pharmacological agents, chemical compounds, proteins, and methodologies that have not yet been implemented in clinical practice are currently being investigated to restore the Th17/Treg balance to treat AR (Table 6)
